Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 819

1.

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.

Naumann-Winter F, Greb A, Borchmann P, Bohlius J, Engert A, Schnell R.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD004626. doi: 10.1002/14651858.CD004626.pub3. Review.

PMID:
23076906
2.

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD007678. doi: 10.1002/14651858.CD007678.pub2. Review.

PMID:
22258971
3.

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.

Rancea M, Monsef I, von Tresckow B, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2013 Jun 20;(6):CD009411. doi: 10.1002/14651858.CD009411.pub2. Review.

PMID:
23784872
4.

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults.

Greb A, Bohlius J, Schiefer D, Schwarzer G, Schulz H, Engert A.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004024. doi: 10.1002/14651858.CD004024.pub2. Review.

PMID:
18254036
5.

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.

Hartmann T, Hübel K, Monsef I, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2015 Oct 20;(10):CD010615. doi: 10.1002/14651858.CD010615.pub2. Review.

PMID:
26484982
6.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
7.

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.

Farquhar C, Marjoribanks J, Basser R, Hetrick S, Lethaby A.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003142. Review.

PMID:
16034887
8.

Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.

Peinemann F, Smith LA, Bartel C.

Cochrane Database Syst Rev. 2013 Aug 7;(8):CD008216. doi: 10.1002/14651858.CD008216.pub4. Review.

PMID:
23925699
9.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, van Dalen EC.

Cochrane Database Syst Rev. 2015 Oct 5;(10):CD006301. doi: 10.1002/14651858.CD006301.pub4. Review.

PMID:
26436598
10.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
12.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
13.

Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis.

Al Khabori M, de Almeida JR, Guyatt GH, Kuruvilla J, Crump M.

J Natl Cancer Inst. 2012 Jan 4;104(1):18-28. doi: 10.1093/jnci/djr450. Review.

14.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.

15.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301. doi: 10.1002/14651858.CD006301.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD006301.

PMID:
23970444
16.

Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.

Papaioannou D, Rafia R, Rathbone J, Stevenson M, Buckley Woods H, Stevens J.

Health Technol Assess. 2012;16(37):1-253, iii-iv. Review.

17.

High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.

Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP 3rd.

Biol Blood Marrow Transplant. 2007 Feb;13(2):183-96. Review.

18.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

19.

Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.

Ashfaq K, Yahaya I, Hyde C, Andronis L, Barton P, Bayliss S, Chen YF.

Health Technol Assess. 2010 Dec;14(54):iii-iv, ix-xi, 1-141. doi: 10.3310/hta14540. Review.

20.

Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Kumar A, Kharfan-Dabaja MA, Glasmacher A, Djulbegovic B.

J Natl Cancer Inst. 2009 Jan 21;101(2):100-6. doi: 10.1093/jnci/djn439. Review.

Items per page

Supplemental Content

Support Center